An Act To Promote Early Detection of Breast Cancer
Maine Legislature, Session 128, LD 0817
Committee Amendment CA_A_S117 (Senate)

COMMITTEE AMENDMENT "A " to S.P. 262, L.D. 817, Bill, "An Act To 
Promote Early Detection of Breast Cancer" 
Amend the bill in section 1 in §4320-K in the first line (page 1, line 3 in L.D.) by 
striking out the following: "screening magnetic resonance imaging scan" and inserting 
the following: 'additional screening of dense breast tissue' 
Amend the bill in section 1 in §4320-K by striking out all of subsection 2 (page 1, 
lines 12 to 14 in L.D.) and inserting the following: 
'2. Required coverage. A carrier offering a health plan in this State shall provide 
coverage for an ultrasound evaluation, a magnetic resonance imaging scan, 3-dimensional 
mammography or additional testing of an entire breast or breasts after a baseline 
mammogram examination if: 
A. The mammogram results demonstrate dense breast tissue; 
B. The mammogram results are abnormal within any degree of breast density; or 
C. The enrollee has additional risk factors for breast cancer, including but not limited 
to family history of breast cancer, prior personal history of breast cancer, positive 
genetic testing, dense breast tissue or other indications as determined by the enrollee's 
health care provider. 
The coverage required in this section may be subject to utilization review by the carrier, 
including periodic review of the medical necessity of the additional screening and 
diagnostic testing. 
Sec. 2. Application. The requirements of this Act apply to all policies, contracts 
and certificates executed, delivered, issued for delivery, continued or renewed in this 
State on or after January 1, 2019. For purposes of this Act, all contracts are deemed to be 
renewed no later than the next yearly anniversary of the contract date. 
Sec. 3. Exemption from review. Notwithstanding the Maine Revised Statutes, 
Title 24-A, section 2752, this Act is enacted without review and evaluation by the 
Department of Professional and Financial Regulation, Bureau of Insurance.' 
Page I - 128LR0213(02)-l 
COMMITTEE AMENDMENT 
ttOfS 
COMMITTEE AMENDMENT 'p.. "to S.P. 262, L.D. 817 
SUMMARY 
This amendment is the minority report of the committee. The amendment requires 
health insurance carriers to provide coverage for an ultrasound evaluation, a magnetic 
resonance imaging scan, 3-dimensional mammography or additional testing of an entire 
breast or breasts after a baseline mammogram examination if the mammogram results 
demonstrate dense breast tissue or are abnormal within any degree of breast density or if 
the person has certain risk factors for breast cancer. The bill limits coverage to a magnetic 
resonance imaging scan. The requirements apply to all individual and group policies and 
contracts issued or renewed on or after January 1, 2019. The amendment also adds 
language exempting the bill from the provisions of the Maine Revised Statutes, Title 24-
A, section 2752. 
J.-' J.St'AL NOTE REQUIRED 
(See Attached) 
COMMITTEE AMENDMENT 
Approved: 05/12/17 feac 
LD 817 
LR213(02) 
An Act To Promote Early Detection of Breast Cancer 
Fiscal Note for Bill as Amended by Committee Amendment "A.' 
Committee: Insurance and Financial Services 
c~-\\-0 
Net Cost (Savings) . 
General Fund 
Highway Fund 
Appropriations/ Allocations 
General Fund 
Highway Fund 
Fiscal Detail and Notes 
Fiscal Note Required: Yes 
Fiscal Note 
FY 2017-18 
$0 
$0 
$0 
$0 
FY 2018-19 
$0 
$0 
$0 
$0. 
Projections 
FY 2019-20 
$55,389 
$1,654 
$55,389 
$1,654 
Projections 
FY 2020-21 
$55,389 
$1,654 
$55,389 
$1,654 
The bill has an effective date of January 1, 2019, so only contracts executed after January 1, 2019 will be required to 
meet the coverage in this bill. Thus, the State Employee Health Plan will require no General Fund appropriations or 
Highway Fund allocations in the current biennium. It is estimated that this bill will have an annual impact of $55 ,3 89 
to the General Fund and $1,654 to the Highway Fund for the increased costs for coverage of additional breast cancer 
screening beginning on July 1, 2019. 
LR0213(02) - Fiscal Note - Page 1 of 1